These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 33821664)

  • 21. Delivery of gene and cellular therapies for heart disease.
    Mariani JA; Kaye DM
    J Cardiovasc Transl Res; 2010 Aug; 3(4):417-26. PubMed ID: 20559776
    [TBL] [Abstract][Full Text] [Related]  

  • 22. On the Road to Regeneration: "Tools" and "Routes" Towards Efficient Cardiac Cell Therapy for Ischemic Cardiomyopathy.
    Pagano F; Picchio V; Chimenti I; Sordano A; De Falco E; Peruzzi M; Miraldi F; Cavarretta E; Zoccai GB; Sciarretta S; Frati G; Marullo AGM
    Curr Cardiol Rep; 2019 Oct; 21(11):133. PubMed ID: 31673821
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Beating and arrested intramyocardial injections are associated with significant mechanical loss: implications for cardiac cell transplantation.
    Hudson W; Collins MC; deFreitas D; Sun YS; Muller-Borer B; Kypson AP
    J Surg Res; 2007 Oct; 142(2):263-7. PubMed ID: 17719065
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human bone marrow-derived adult stem cells for post-myocardial infarction cardiac repair: current status and future directions.
    Wei HM; Wong P; Hsu LF; Shim W
    Singapore Med J; 2009 Oct; 50(10):935-42. PubMed ID: 19907881
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Choice of cell-delivery route for skeletal myoblast transplantation for treating post-infarction chronic heart failure in rat.
    Fukushima S; Coppen SR; Lee J; Yamahara K; Felkin LE; Terracciano CM; Barton PJ; Yacoub MH; Suzuki K
    PLoS One; 2008 Aug; 3(8):e3071. PubMed ID: 18728781
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cell-based therapy for heart disease: a clinically oriented perspective.
    Menasche P
    Mol Ther; 2009 May; 17(5):758-66. PubMed ID: 19277020
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cellular mechanisms underlying cardiac engraftment of stem cells.
    Kanda P; Davis DR
    Expert Opin Biol Ther; 2017 Sep; 17(9):1127-1143. PubMed ID: 28670973
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regenerative medicine for the heart: perspectives on stem-cell therapy.
    Cho GS; Fernandez L; Kwon C
    Antioxid Redox Signal; 2014 Nov; 21(14):2018-31. PubMed ID: 25133793
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Route of Delivery Modulates the Efficacy of Mesenchymal Stem Cell Therapy for Myocardial Infarction: A Meta-Analysis of Preclinical Studies and Clinical Trials.
    Kanelidis AJ; Premer C; Lopez J; Balkan W; Hare JM
    Circ Res; 2017 Mar; 120(7):1139-1150. PubMed ID: 28031416
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cardiac Cell Therapy: Insights into the Mechanisms of Tissue Repair.
    Peng H; Shindo K; Donahue RR; Abdel-Latif A
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33530466
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Technologies for intrapericardial delivery of therapeutics and cells.
    Filgueira CS; Igo SR; Wang DK; Hirsch M; Schulz DG; Bruckner BA; Grattoni A
    Adv Drug Deliv Rev; 2019; 151-152():222-232. PubMed ID: 30797957
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Potential benefits of cell therapy in coronary heart disease.
    Grimaldi V; Mancini FP; Casamassimi A; Al-Omran M; Zullo A; Infante T; Napoli C
    J Cardiol; 2013 Nov; 62(5):267-76. PubMed ID: 23834957
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Radiolabeled cell distribution after intramyocardial, intracoronary, and interstitial retrograde coronary venous delivery: implications for current clinical trials.
    Hou D; Youssef EA; Brinton TJ; Zhang P; Rogers P; Price ET; Yeung AC; Johnstone BH; Yock PG; March KL
    Circulation; 2005 Aug; 112(9 Suppl):I150-6. PubMed ID: 16159808
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dual-modal tracking of transplanted mesenchymal stem cells after myocardial infarction.
    Li Y; Yao Y; Sheng Z; Yang Y; Ma G
    Int J Nanomedicine; 2011; 6():815-23. PubMed ID: 21589649
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cell administration routes for heart failure: a comparative re-evaluation of the REGENERATE-DCM and REGENERATE-IHD trials.
    Sim DS; Jones DA; Davies C; Locca D; Veerapen J; Reid A; Godec T; Martin J; Mathur A
    Regen Med; 2022 Dec; 17(12):891-903. PubMed ID: 36226504
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Wnt Signaling: The double-edged sword diminishing the potential of stem cell therapy in congenital heart disease.
    Mohamed IA; El-Badri N; Zaher A
    Life Sci; 2019 Dec; 239():116937. PubMed ID: 31629761
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Delivery of drugs, growth factors, genes and stem cells via intrapericardial, epicardial and intramyocardial routes for sustained local targeted therapy of myocardial disease.
    Maslov M; Foianini S; Lovich M
    Expert Opin Drug Deliv; 2017 Oct; 14(10):1227-1239. PubMed ID: 28276968
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cell distribution after intracoronary bone marrow stem cell delivery in damaged and undamaged myocardium: implications for clinical trials.
    Forest VF; Tirouvanziam AM; Perigaud C; Fernandes S; Fusellier MS; Desfontis JC; Toquet CS; Heymann MF; Crochet DP; Lemarchand PF
    Stem Cell Res Ther; 2010 Mar; 1(1):4. PubMed ID: 20504285
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hopes and Hurdles of Employing Mesenchymal Stromal Cells in the Treatment of Cardiac Fibrosis.
    Neuber S; Emmert MY; Nazari-Shafti TZ
    Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884805
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stem cells and cardiac repair: a critical analysis.
    Dinsmore JH; Dib N
    J Cardiovasc Transl Res; 2008 Mar; 1(1):41-54. PubMed ID: 20559957
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.